Daylight photodynamic therapy with methyl aminolevulinate cream is effective and nearly painless in treating actinic keratoses: a randomised, investigator‐blinded, controlled, phase <scp>III</scp> study throughout Europe
Daylight photodynamic therapy with methyl aminolevulinate cream is effective and nearly painless in treating actinic keratoses: a randomised, investigator‐blinded, controlled, phase <scp>III</scp> study throughout Europe is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Daylight photodynamic therapy with methyl aminolevulinate cream is effective and nearly painless in treating actinic keratoses: a randomised, investigator‐blinded, controlled, phase <scp>III</scp> study throughout Europe have?
Daylight photodynamic therapy with methyl aminolevulinate cream is effective and nearly painless in treating actinic keratoses: a randomised, investigator‐blinded, controlled, phase <scp>III</scp> study throughout Europe has 146 citations in the OpenAlex counts ScholarIQ stores.
When was Daylight photodynamic therapy with methyl aminolevulinate cream is effective and nearly painless in treating actinic keratoses: a randomised, investigator‐blinded, controlled, phase <scp>III</scp> study throughout Europe published?
Daylight photodynamic therapy with methyl aminolevulinate cream is effective and nearly painless in treating actinic keratoses: a randomised, investigator‐blinded, controlled, phase <scp>III</scp> study throughout Europe has 2015 year in the ScholarIQ index.
What is the open-access status of Daylight photodynamic therapy with methyl aminolevulinate cream is effective and nearly painless in treating actinic keratoses: a randomised, investigator‐blinded, controlled, phase <scp>III</scp> study throughout Europe?
Daylight photodynamic therapy with methyl aminolevulinate cream is effective and nearly painless in treating actinic keratoses: a randomised, investigator‐blinded, controlled, phase <scp>III</scp> study throughout Europe has closed oa status in the ScholarIQ index.
What is the DOI of Daylight photodynamic therapy with methyl aminolevulinate cream is effective and nearly painless in treating actinic keratoses: a randomised, investigator‐blinded, controlled, phase <scp>III</scp> study throughout Europe?
The DOI for Daylight photodynamic therapy with methyl aminolevulinate cream is effective and nearly painless in treating actinic keratoses: a randomised, investigator‐blinded, controlled, phase <scp>III</scp> study throughout Europe is on the source record.
What is the PMID of Daylight photodynamic therapy with methyl aminolevulinate cream is effective and nearly painless in treating actinic keratoses: a randomised, investigator‐blinded, controlled, phase <scp>III</scp> study throughout Europe?
The PMID for Daylight photodynamic therapy with methyl aminolevulinate cream is effective and nearly painless in treating actinic keratoses: a randomised, investigator‐blinded, controlled, phase <scp>III</scp> study throughout Europe is on the source record.
What is the OpenAlex record for Daylight photodynamic therapy with methyl aminolevulinate cream is effective and nearly painless in treating actinic keratoses: a randomised, investigator‐blinded, controlled, phase <scp>III</scp> study throughout Europe?
The OpenAlex for Daylight photodynamic therapy with methyl aminolevulinate cream is effective and nearly painless in treating actinic keratoses: a randomised, investigator‐blinded, controlled, phase <scp>III</scp> study throughout Europe is on the source record.